GLP-1 receptor agonists and similar drugs may protect people with opioid or alcohol use disorder from opioid overdose and ...

Patients aged 10 to 17 years who are prescribed glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are more likely to have comorbid type 2 diabetes, high body mass index, and a previous metformin ...

Newer weight loss drugs are cost effective in the long term only when combined with bariatric weight loss surgery, according ...

Weight-loss and diabetes drugs like Ozempic, Wegovy, Mounjaro or Zepbound appear to help people battle alcoholism and opioid ...

For adolescents with obesity, glucagon-like peptide 1 receptor agonist (GLP1-RA) treatment is associated with a reduc ...

The FDA has already made more than a dozen cancer drug approval decisions this year and more expected in the next several ...

Weight-loss and diabetes drugs like Ozempic, Wegovy, Mounjaro or Zepbound appear to help people battle alcoholism and opioid ...

Patients aged 10 to 17 years who are prescribed glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are more likely to have ...

Ozempic and other semaglutide medications for weight loss have been linked to hair loss on social media. Experts share who is ...

Both Wegovy and Mounjaro are given as weekly injections via pre-filled pens that can be self-administered into the upper arm, ...

As previously reported in Women’s Health, semaglutide injections mimic the effects of a hormone called glucagon-like ...

In a huge new statistical analysis, researchers have found more evidence than ever that drugs like Ozempic can help curb ...